Related Experiment Videos
Behçet's syndrome: ocular features in an Australian population
1Laboratory of Ocular Immunology, School of Pathology, University of NSW, Australia.
Summary
Behçet's syndrome (BS) rarely causes inflammatory eye disease (IED) in Australia. Ocular involvement is key for diagnosing this severe, recurrent condition, but visual prognosis remains guarded.
Area of Science:
- Ophthalmology
- Rheumatology
- Immunology
Background:
- Inflammatory eye disease (IED) is a severe manifestation of Behçet's syndrome (BS).
- BS is a common cause of uveitis in Mediterranean regions, the Middle East, and Japan.
- Prevalence of BS-related IED in Australia is not well-established.
Purpose of the Study:
- To determine the prevalence of Behçet's syndrome (BS) among patients with inflammatory eye disease (IED) in Australia.
- To describe the clinical features and visual outcomes of ocular inflammation in Australian BS patients.
Main Methods:
- Retrospective review of 426 patients with inflammatory eye disease attending a uveitis clinic over five years.
- Diagnosis of definite Behçet's syndrome based on established criteria.
- Analysis of ocular manifestations, including anterior/posterior uveitis, retinal vasculitis, and optic neuritis.
Main Results:
- Twelve out of 426 patients (2.8%) had definite Behçet's syndrome.
- Ocular manifestations included anterior uveitis, posterior uveitis, retinal vasculitis, and optic neuritis.
- IED was the presenting feature leading to diagnosis in most cases, characterized by severity, recurrence, and significant vision loss.
Conclusions:
- Behçet's syndrome is a rare cause of IED in Australia.
- Ocular involvement is crucial for diagnosing BS, often preceding other systemic features.
- Visual prognosis for ocular inflammation in BS is guarded, even with immunosuppressive therapy.